• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

mergers and acquisitions - Articles and news items

viridian pharma

Martindale expands hospital-initiated medicines portfolio through Viridian acquisition

Industry news / 11 July 2016 / Victoria White, Digital Content Producer

Viridian Pharma has developed five products that have regulatory approval in the UK and represent first-to-market specialty hospital-prescribed medicines…

Medivation’s Board

Medivation in confidentiality agreements with Sanofi and others

Industry news / 6 July 2016 / Victoria White, Digital Content Producer

Medivation has entered into confidentiality agreements with parties that have expressed interest in exploring a potential transaction to acquire the company…

cormorant pharmaceuticals

Bristol-Myers Squibb acquires Cormorant Pharmaceuticals

Industry news / 5 July 2016 / Victoria White, Digital Content Producer

The acquisition gives Bristol-Myers Squibb full rights to Cormorant Pharmaceuticals’ HuMax-IL8 antibody programme…

afferent

Merck to acquire Afferent Pharmaceuticals

Industry news / 10 June 2016 / Victoria White, Digital Content Producer

Merck, known as MSD outside the US and Canada, has announced that it is is to acquire Afferent Pharmaceuticals…

baxalta

Shire and Baxalta combine to create a global leader in rare diseases

Industry news / 3 June 2016 / Victoria White, Digital Content Producer

Shire and Baxalta have combined businesses, creating a leading global company focused on rare diseases and other highly specialised conditions…

celator

Jazz Pharmaceuticals to acquire Celator for $1.5 billion

Industry news / 31 May 2016 / Victoria White, Digital Content Producer

The transaction advances Jazz Pharmaceuticals’ growth strategy and adds Celator’s investigational therapy Vyxeous to the company’s portfolio…

Medivation’s Board

Sanofi files consent solicitation to replace Medivation’s Board

Industry news / 25 May 2016 / Victoria White, Digital Content Producer

Sanofi says it had ‘no choice’ but to commence a process to elect eight independent directors who are more open to evaluating Sanofi’s takeover proposal…

Alizé-Pharma-II

Jazz Pharmaceuticals acquires 100% of the shares of Alizé Pharma II

Industry news / 11 May 2016 / Victoria White, Digital Content Producer

A subsidiary of Jazz Pharmaceuticals has acquired 100% of the shares of Alizé Pharma II in a deal valued at up to €18 million…

ariad

Incyte to acquire ARIAD’s European operations for $140m

Industry news / 9 May 2016 / Victoria White, Digital Content Producer

The companies will also enter into a license agreement whereby Incyte will obtain an exclusive license to develop and commercialise Iclusig…

Haemostatix

Ergomed proposes acquisition of Haemostatix

Industry news / 5 May 2016 / Victoria White, Digital Content Producer

Ergomed is acquiring 100% of the issued share capital of Haemostatix for an initial consideration of £8.0 million…

Medivation’s Board

Medivation’s Board rejects Sanofi’s unsolicited proposal

Industry news / 3 May 2016 / Victoria White, Digital Content Producer

Medivation’s Board has determined that the proposal from Sanofi to acquire Medivation for $52.50 per share substantially undervalues the company…

Medivation’s Board

Sanofi makes $9.3b offer to acquire Medivation

Industry news / 28 April 2016 / Victoria White, Digital Content Producer

Sanofi has made an unsolicited $9.3 billion offer to acquire Medivation, the maker of prostate cancer drug Xtandi…

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +